Q and A on spinal cord injury
Dr. Heakyung Kim of the University of Texas Southwestern Medical Center answered questions from the community about spinal cord injuries.
Symptom management panel
Paula Hardeman, Crystal Wright, Dr. Lindsay Horton, and Dr. Rajashree Srinivasan talked about how to manage symptoms following diagnosis.
Deliberations on acute and long-term treatment guidance
Dr. Benjamin Greenberg and Dr. Michael Levy discussed acute and long-term treatments, including approved and off-label therapies.
Is it a relapse or recurrence?
Dr. Lauren Tardo discussed the difference between a relapse and a recurrence, and how to recognize these events in order to seek medical care.
Unlocking controversies around causation
In this panel discussion Dr. Benjamin Greenberg and Michael Levy reviewed current understanding and knowledge, and answered questions.
Unlocking the diagnostic odyssey
At the 2023 Regional RNDS, Dr. Kyle Blackburn described the diagnoses of ADEM, AFM, MOGAD, NMOSD, ON, and TM, and answered questions.
2023 RNDS | Welcome
To kick off the 2023 RNDS, we heard from SRNA’s President, Sandy Siegel and SRNA Board Member Dr. Benjamin Greenberg.
2022 RNDS | Q&A and Closing Remarks
The last Q&A of the 2022 Rare Neuroimmune Disorders Symposium (RNDS) included a medical expert panel and closing remarks by Dr. Carlos Pardo.
APERTURE: New Insights on ADEM
Join us to hear from Dr. Cynthia Wang about the latest findings in her research of rare neuroimmune disorders at the 2022 RNDS.
Association of rare variants in genes of immune regulation with pediatric autoimmune CNS disease
Join us to hear from Dr. Saba Jafarpour about the latest findings in her research of rare neuroimmune disorders at the 2022 RNDS.
